Yatsen (YSG) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
17 Nov, 2025Executive summary
Achieved fourth consecutive quarter of revenue growth, with Q3 2025 net revenues up 47.5% year-over-year to RMB 998.4 million, driven by strong skincare and color cosmetics performance.
Skincare brands grew 83.2% year-over-year, now comprising 49.2% of total revenue, supporting a margin-accretive portfolio shift.
Gross margin improved to 78.2% from 75.9% year-over-year, reflecting a shift to higher-margin products.
Net loss margin improved to 7% from 17.9% in the prior year; non-GAAP net loss margin narrowed to 5.2%.
Focus remains on R&D, innovation, and disciplined capital allocation to drive sustainable long-term growth.
Financial highlights
Total net revenues for Q3 2025 were RMB 998.4 million, up 47.5% year-over-year.
Gross profit increased 51.9% to RMB 780.5 million; gross margin rose to 78.2% from 75.9%.
Net loss narrowed to RMB 70.4 million (net loss margin 7%), compared to RMB 121.1 million (17.9%) a year ago.
Non-GAAP net loss was RMB 51.5 million (margin 5.2%), down from RMB 76.6 million (11.3%).
Cash, restricted cash, and short-term investments stood at RMB 1.16 billion as of September 30, 2025.
Outlook and guidance
Q4 2025 net revenues expected between RMB 1.32 billion and RMB 1.49 billion, a 15%–30% year-over-year increase.
Management expects continued improvement in profitability, driven by higher skincare mix, marketing efficiency, and cost structure optimization.
Forward-looking statements are subject to risks and uncertainties, including market and operational factors.
Latest events from Yatsen
- Q2 2025 revenue rose 36.8%, skincare led growth, and net loss narrowed sharply.YSG
Q2 202517 Mar 2026 - Skincare-led growth drove profitability and margin gains, with strong outlook for 2026.YSG
Q4 20252 Mar 2026 - Net revenues fell 7.5% as Color Cosmetics declined, but Skincare grew and margins improved.YSG
Q2 202423 Jan 2026 - Gross margin rose to 75.9% as net loss narrowed and skincare brands gained share.YSG
Q3 202413 Jan 2026 - Q4 revenues grew 7.1% with margin gains and non-GAAP profit, outpacing a weak market.YSG
Q4 202423 Dec 2025 - Skincare growth and margin gains drove a return to non-GAAP profitability in Q1 2025.YSG
Q1 202521 Nov 2025